Tramadol, an opioid analgesic for moderate pain, and Wegovy (semaglutide), a GLP-1 receptor agonist for weight management, are not contraindicated together
These findings suggested that sustained proexendin-4 expression may break immune tolerance and simultaneously activate humoral and cellular immune responses
References SURMOUNT-5 head-to-head trial (NEJM, May 2025) summary via American College of Cardiology: SURPASS-2 primary publication (NEJM, 2021): Eli Lilly SURMOUNT-1 results announcement (NEJM data): Insights into the Mechanism of Action of Tirzepatide (PMC narrative review): Tirzepatide is an imbalanced and biased dual GIP/GLP-1 receptor agonist (PMC): SURMOUNT-5 GI tolerability / discontinuation data (Applied Clinical Trials, tctmd, DiabetesontheNet coverage): SURMOUNT-1 to -4 GI tolerability (Rubino 2025, Diabetes Obesity & Metabolism): Community sentiment context Reddit GLP-1 side-effect analysis and comparative meta-analyses (PMC): Research Use Only Notice: The content on this page is provided for informational and educational purposes only
Victoza may increase the chance of food getting into your lungs during surgery or other procedures
Prepare for your appointment by: Documenting your weight history, including previous weight loss attempts, diets tried, exercise programs, and any medications used Listing current medications, supplements, and medical conditions Recording weight-related health concerns such as joint pain, sleep problems, or mobility limitations Writing down specific questions about treatment options, risks, and expected outcomes Bringing recent laboratory results if available During the consultation, be honest about your struggles with weight management and your treatment goals
